Rachel C. Quilang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rachel C. Quilang has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Katja Sallinger
Department of Cell Biology Histology & Embryology Gottfried Schatz Research Center Medical University of Graz Graz 8010 Austria
2 shared publications - Kristine Joy Chua
Department of Anthropology, University of Notre Dame, Indiana, USA; Eck Institute for Global Health, University of Notre Dame, Indiana, USA
2 shared publications - Michael Eikmans
Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands
2 shared publications - Thomas Kroneis
Department of Cell Biology Histology & Embryology Gottfried Schatz Research Center Medical University of Graz Graz 8010 Austria
2 shared publications - Amy M. Boddy
Department of Anthropology, University of California Santa Barbara, Santa Barbara, USA
1 shared publication - Anders Ståhlberg
Department of Laboratory Medicine, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
1 shared publication
Latest Publications
- Open Access
- 24 October 2025
- Published by Wiley in Advanced Science
- Vol. 12 (48) , e14969
Identifying Key Questions and Challenges in Microchimerism Biology
Microchimerism research has recently gained renewed attention despite known existence of these rare cells for decades. Fetal and maternal microchimeric‐derived cells may have functional capabilities, and are increasingly associated with both beneficial and adverse health outcomes. Yet, establishing the role of microchimerism in health has been largely constrained methodologically and theoretically. The Microchimerism, Human Health, and Evolution Project address these challenges by calling on 29 leading microchimerism experts to put forth key research questions that can substantially advance the field. Seven major categories are identified: function and mechanism; microchimerism in interventions, treatment, and transplant; mapping “generational microchimerism”; evolution; microchimerism detection; appropriate experimental model systems; and definition of microchimerism. Identifying these questions ‐ and continuing to find answers ‐ will be crucial for advancing the knowledge of microchimerism in health and disease.
- 24 October 2025
- Published by Wiley in Advanced Science
- Vol. 12 (48) , e14969
Open AccessIdentifying Key Questions and Challenges in Microchimerism Biology
Microchimerism research has recently gained renewed attention despite known existence of these rare cells for decades. Fetal and maternal microchimeric‐derived cells may have functional capabilities, and are increasingly associated with both beneficial and adverse health outcomes. Yet, establishing the role of microchimerism in health has been largely constrained methodologically and theoretically. The Microchimerism, Human Health, and Evolution Project address these challenges by calling on 29 leading microchimerism experts to put forth key research questions that can substantially advance the field. Seven major categories are identified: function and mechanism; microchimerism in interventions, treatment, and transplant; mapping “generational microchimerism”; evolution; microchimerism detection; appropriate experimental model systems; and definition of microchimerism. Identifying these questions ‐ and continuing to find answers ‐ will be crucial for advancing the knowledge of microchimerism in health and disease.
- Open Access
- 17 January 2025
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 47 (1) , 1-13
Maternal microchimeric cell trafficking and its biological consequences depend on the onset of inflammation at the feto-maternal interface
Microchimerism is defined as the presence of a small population of genetically distinct cells within a host that is derived from another individual. Throughout pregnancy, maternal and fetal cells are known to traffic across the feto-maternal interface and result in maternal and fetal microchimerism, respectively. However, the routes of cell transfer, the molecular signaling as well as the timing in which trafficking takes place are still not completely understood. Recently, the presence of inflammation at the feto-maternal interface has been linked with maternal microchimeric cells modulating organ development in the fetus. Here, we review the current literature and suggest that inflammatory processes at the feto-maternal interface tissues are a physiological prerequisite for the establishment of microchimerism. We further propose a spatio-temporal corridor of microchimeric cell migration to potentially explain some biological effects of microchimerism. Additionally, we elaborate on the possible consequences of a shift in this spatio-temporal corridor, potentially responsible for the development of pathologies in the neonate.
- 17 January 2025
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 47 (1) , 1-13
Open AccessMaternal microchimeric cell trafficking and its biological consequences depend on the onset of inflammation at the feto-maternal interface
Microchimerism is defined as the presence of a small population of genetically distinct cells within a host that is derived from another individual. Throughout pregnancy, maternal and fetal cells are known to traffic across the feto-maternal interface and result in maternal and fetal microchimerism, respectively. However, the routes of cell transfer, the molecular signaling as well as the timing in which trafficking takes place are still not completely understood. Recently, the presence of inflammation at the feto-maternal interface has been linked with maternal microchimeric cells modulating organ development in the fetus. Here, we review the current literature and suggest that inflammatory processes at the feto-maternal interface tissues are a physiological prerequisite for the establishment of microchimerism. We further propose a spatio-temporal corridor of microchimeric cell migration to potentially explain some biological effects of microchimerism. Additionally, we elaborate on the possible consequences of a shift in this spatio-temporal corridor, potentially responsible for the development of pathologies in the neonate.